Associate Methods Specialist

Scorpion Therapeutics; De Soto (KS); On-site; USD 72,000 - 113,000; Full time

Benefits offered by this job

Medical/dental/vision insurance

401(k) plan

Paid holidays and vacation

Job summary

Scorpion Therapeutics is seeking a biologically minded analyst to support remediation of analytical methods and oversee method transfers. The role focuses on biomaterial assessments, data trending, and cross-site coordination to ensure robust and compliant test practices.

You will author validation reports and regulatory submissions, while collaborating with QA, manufacturing, and R&D teams, ensuring timely delivery and training across sites.

Qualifications

• 1–3 years bench experience in in vitro bioassay development/testing.
• 1–3 years in animal health QC/R&D/technical support; familiarity with USDA regulations.
• Expertise in at least one bioassay platform (ELISA, virus titration, HA/HI) plus data analysis/interpretation.
• Strong technical writing; effective cross-functional communication.

Responsibilities

• Support data analysis and trending to identify non-robust methods and remediation planning.
• Perform bench-level remediation across test platforms including ELISA and titration.
• Author remediation protocols, validation reports, and regulatory submissions.
• Support post-remediation change control and verify sustained performance.
• Lead/coordinate method transfers across sites with timelines and deliverables.
• Assess site capabilities and design remediation/training plans.
• Provide hands-on training during transfers and oversee documentation.
• Monitor post-transfer performance to ensure robustness and resolve issues.
• Use project systems to track progress, manage risks, and report metrics.

Skills

Data analysis & trending

Biomaterials/testing knowledge

Excellent technical writing

Cross-functional communication

Education

Bachelor’s degree in Biology/Immunology/Virology

Tools

ELISA

Virus titration

HA/HI assays

Job description

Role Responsibilities

• Support complex data analysis/trending to identify non-robust or out-of-specification methods; conduct biomaterials assessments, inventory reviews, and document gap analyses for remediation.
• Perform bench-level remediation across test platforms (live bacterial/virus titration/identification; ELISA for multivalent vaccines and in-process materials).
• Author method remediation protocols, validation reports, and USDA regulatory submissions; update internal/regulatory procedures.
• Support post-remediation change control and verification of sustained method performance.
• Participate/lead cross-functional site-to-site analytical method transfers; coordinate timelines/deliverables.
• Assess site capabilities (skills, instrumentation, lab operations) and implement remediation/training plans.
• Provide hands-on training during transfers and oversee transfer/validation documentation.
• Support post-transfer monitoring to confirm robustness and resolve residual issues.
• Use internal project systems to track progress, manage risks, and report metrics; present updates and recommend risk mitigations.

Education

• Bachelor’s degree in Biology, Genetics, Immunology, Microbiology, Virology, or related biological science.

Required Experience/Skills

• 1–3 years bench experience in in vitro bioassay development/testing/troubleshooting.
• 1–3 years in animal health QC/R&D/technical support; familiarity with USDA regulations.
• Expertise in at least one bioassay platform (e.g., ELISA, virus titration, HA/HI) plus data analysis/trending/interpretation.
• Strong technical writing; effective cross-functional communication.

Preferred

• Experience troubleshooting analytical methods for complex vaccines/in-process materials; bioassay experimental design; analytical tech (imagers, liquid handlers); presenting results to stakeholders.

Benefits/Pay/Apply

• Salary range: $71,900–$113,200; eligible for annual bonus/long-term incentive (if applicable). Benefits include medical/dental/vision, 401(k), paid holidays/vacation, and sick/compassionate days.